VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q44359561 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000035.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q44359561‏
024 ‎‡a 0000-0003-0239-0973‏ ‎‡2 orcid‏
024 ‎‡a 55827380400‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q44359561‏
100 0 ‎‡a James A. Hall‏ ‎‡9 es‏ ‎‡9 sl‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a জেমস এ হল‏ ‎‡c গবেষক‏ ‎‡9 bn‏
400 0 ‎‡a James A. Hall‏ ‎‡c researcher (ORCID 0000-0003-0239-0973)‏ ‎‡9 en‏
400 0 ‎‡a James A. Hall‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation‏
670 ‎‡a Author's A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned‏
670 ‎‡a Author's A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial‏
670 ‎‡a Author's Acute myocarditis secondary to Campylobacter jejuni enterocolitis‏
670 ‎‡a Author's An unexpected finding during planned primary percutaneous coronary angioplasty.‏
670 ‎‡a Author's Authors' Reply to the Letter by Madias Entitled ' "Bronchogenic Stress Cardiomyopathy", a subset of Takotsubo Syndrome'‏
670 ‎‡a Author's Bradycardia due to anthracyclines‏
670 ‎‡a Author's Bronchogenic stress cardiomyopathy: a case series‏
670 ‎‡a Author's Cardiac beta 2-adrenoceptor stimulation in humans‏
670 ‎‡a Author's Cardiac catheterisation: radiation doses and lifetime risk of malignancy.‏
670 ‎‡a Author's Compression of main pulmonary artery by giant saphenous vein graft aneurysm‏
670 ‎‡a Author's Cumulative funnel plots for the early detection of interoperator variation: retrospective database analysis of observed versus predicted results of percutaneous coronary intervention.‏
670 ‎‡a Author's Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.‏
670 ‎‡a Author's Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction‏
670 ‎‡a Author's Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial‏
670 ‎‡a Author's Enoximone potentiates the positive inotropic effects of beta-1- and beta-2-adrenoceptor stimulation in human atrial myocardium‏
670 ‎‡a Author's Extensor mechanism function in single-radius vs multiradius femoral components for total knee arthroplasty‏
670 ‎‡a Author's External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention.‏
670 ‎‡a Author's Impact of catheter sizes and intracoronary glyceryl trinitrate on the TIMI frame count when digital angiograms are acquired at lower frame rates during elective angiography and PCI.‏
670 ‎‡a Author's Impact of implementation of evidence-based strategies to reduce door-to-balloon time in patients presenting with STEMI: continuous data analysis and feedback using a statistical process control plot.‏
670 ‎‡a Author's Large thrombus burden in acute myocardial infarction: successful use of distal protection device following failure of thrombus aspiration‏
670 ‎‡a Author's National variations in the provision of cardiac services in the United Kingdom: second report of the British Cardiac Society Working Group, 2005‏
670 ‎‡a Author's Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery‏
670 ‎‡a Author's Reappraising the role of immediate intervention following thrombolytic recanalization in acute myocardial infarction‏
670 ‎‡a Author's Rescue angioplasty after failed fibrinolysis for acute myocardial infarction: predictors of a failed procedure and 1-year mortality‏
670 ‎‡a Author's Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group‏
670 ‎‡a Author's Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients.‏
670 ‎‡a Author's Simultaneous presentation of coronary heart disease in identical twins‏
670 ‎‡a Author's Successful thrombus extraction with the Rescue thrombus management system during acute percutaneous coronary intervention improves flow but does not necessarily restore optimal myocardial tissue perfusion‏
670 ‎‡a Author's The impact of chronically diseased coronary arteries and stenting on the corrected TIMI frame count in elective coronary angiography and percutaneous coronary intervention procedures‏
670 ‎‡a Author's The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention.‏
909 ‎‡a (scopus) 55827380400‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000302390973‏ ‎‡9 1‏
919 ‎‡a simultaneouspresentationofcoronaryheartdiseaseinidenticaltwins‏ ‎‡A Simultaneous presentation of coronary heart disease in identical twins‏ ‎‡9 1‏
919 ‎‡a cardiacbeta2adrenoceptorstimulationinhumans‏ ‎‡A Cardiac beta 2-adrenoceptor stimulation in humans‏ ‎‡9 1‏
919 ‎‡a earlyinvasiveversusconservativetreatmentinpatientswithfailedfibrinolysisnolatesurvivalbenefitthefinalanalysisofthemiddlesbroughearlyrevascularisationtolimitinfarctionmerlinrandomizedtrial‏ ‎‡A Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial‏ ‎‡9 1‏
919 ‎‡a unexpectedfindingduringplannedprimarypercutaneouscoronaryangioplasty‏ ‎‡A An unexpected finding during planned primary percutaneous coronary angioplasty.‏ ‎‡9 1‏
919 ‎‡a acutemyocarditissecondarytocampylobacterjejunienterocolitis‏ ‎‡A Acute myocarditis secondary to Campylobacter jejuni enterocolitis‏ ‎‡9 1‏
919 ‎‡a randomizedtrialofrescueangioplastyversusaconservativeapproachforfailedfibrinolysisinstsegmentelevationmyocardialinfarctionthemiddlesbroughearlyrevascularizationtolimitinfarctionmerlintrial‏ ‎‡A A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial‏ ‎‡9 1‏
919 ‎‡a enoximonepotentiatesthepositiveinotropiceffectsofbeta1andbeta2adrenoceptorstimulationinhumanatrialmyocardium‏ ‎‡A Enoximone potentiates the positive inotropic effects of beta-1- and beta-2-adrenoceptor stimulation in human atrial myocardium‏ ‎‡9 1‏
919 ‎‡a authorsreplytotheletterbymadiasentitledbronchogenicstresscardiomyopathyasubsetoftakotsubosyndrome‏ ‎‡A Authors' Reply to the Letter by Madias Entitled ' "Bronchogenic Stress Cardiomyopathy", a subset of Takotsubo Syndrome'‏ ‎‡9 1‏
919 ‎‡a bronchogenicstresscardiomyopathyacaseseries‏ ‎‡A Bronchogenic stress cardiomyopathy: a case series‏ ‎‡9 1‏
919 ‎‡a selectiveuseofabciximabincoronarystentingoveralloutcomescanstillbeequivalenttothoseintheepistenttreatmentgroup‏ ‎‡A Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group‏ ‎‡9 1‏
919 ‎‡a earlyandlatereactionsaftertheuseofiopamidol340ioxaglate320andiodixanol320incardiaccatheterization‏ ‎‡A Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.‏ ‎‡9 1‏
919 ‎‡a cumulativefunnelplotsfortheearlydetectionofinteroperatorvariationretrospectivedatabaseanalysisofobservedversuspredictedresultsofpercutaneouscoronaryintervention‏ ‎‡A Cumulative funnel plots for the early detection of interoperator variation: retrospective database analysis of observed versus predicted results of percutaneous coronary intervention.‏ ‎‡9 1‏
919 ‎‡a bradycardiaduetoanthracyclines‏ ‎‡A Bradycardia due to anthracyclines‏ ‎‡9 1‏
919 ‎‡a impactofimplementationofevidencebasedstrategiestoreducedoortoballoontimeinpatientspresentingwithstemicontinuousdataanalysisandfeedbackusingastatisticalprocesscontrolplot‏ ‎‡A Impact of implementation of evidence-based strategies to reduce door-to-balloon time in patients presenting with STEMI: continuous data analysis and feedback using a statistical process control plot.‏ ‎‡9 1‏
919 ‎‡a compressionofmainpulmonaryarterybygiantsaphenousveingraftaneurysm‏ ‎‡A Compression of main pulmonary artery by giant saphenous vein graft aneurysm‏ ‎‡9 1‏
919 ‎‡a largethrombusburdeninacutemyocardialinfarctionsuccessfuluseofdistalprotectiondevicefollowingfailureofthrombusaspiration‏ ‎‡A Large thrombus burden in acute myocardial infarction: successful use of distal protection device following failure of thrombus aspiration‏ ‎‡9 1‏
919 ‎‡a prospectiverandomisedcontrolledtrialtodeterminetheearlyandlatereactionsaftertheuseofiopamidol340niopamandiomeprol350iomeronincardiaccatheterisation‏ ‎‡A A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation‏ ‎‡9 1‏
919 ‎‡a silentmyocardialischaemiainpatientswithprovedcoronaryarterydiseaseacomparisonofdiabeticandnondiabeticpatients‏ ‎‡A Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients.‏ ‎‡9 1‏
919 ‎‡a rescueangioplastyafterfailedfibrinolysisforacutemyocardialinfarctionpredictorsofafailedprocedureand1yearmortality‏ ‎‡A Rescue angioplasty after failed fibrinolysis for acute myocardial infarction: predictors of a failed procedure and 1-year mortality‏ ‎‡9 1‏
919 ‎‡a extensormechanismfunctioninsingleradiusvsmultiradiusfemoralcomponentsfortotalkneearthroplasty‏ ‎‡A Extensor mechanism function in single-radius vs multiradius femoral components for total knee arthroplasty‏ ‎‡9 1‏
919 ‎‡a nationalvariationsintheprovisionofcardiacservicesintheunitedkingdom2reportofthebritishcardiacsocietyworkinggroup‏ ‎‡A National variations in the provision of cardiac services in the United Kingdom: second report of the British Cardiac Society Working Group, 2005‏ ‎‡9 1‏
919 ‎‡a externalvalidationofestablishedriskadjustmentmodelsforproceduralcomplicationsafterpercutaneouscoronaryintervention‏ ‎‡A External validation of established risk adjustment models for procedural complications after percutaneous coronary intervention.‏ ‎‡9 1‏
919 ‎‡a randomizedtrialofprophylacticantiarrhythmicagentsamiodaroneandsotalolinpatientswithatrialfibrillationforwhomdirectcurrentcardioversionisplanned‏ ‎‡A A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned‏ ‎‡9 1‏
919 ‎‡a impactofchronicallydiseasedcoronaryarteriesandstentingonthecorrectedtimiframecountinelectivecoronaryangiographyandpercutaneouscoronaryinterventionprocedures‏ ‎‡A The impact of chronically diseased coronary arteries and stenting on the corrected TIMI frame count in elective coronary angiography and percutaneous coronary intervention procedures‏ ‎‡9 1‏
919 ‎‡a primarypercutaneouscoronaryinterventionforacutestsegmentelevationmyocardialinfarctionchangingpatternsofvascularaccessradialversusfemoralartery‏ ‎‡A Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery‏ ‎‡9 1‏
919 ‎‡a reappraisingtheroleofimmediateinterventionfollowingthrombolyticrecanalizationinacutemyocardialinfarction‏ ‎‡A Reappraising the role of immediate intervention following thrombolytic recanalization in acute myocardial infarction‏ ‎‡9 1‏
919 ‎‡a impactofcathetersizesandintracoronaryglyceryltrinitrateonthetimiframecountwhendigitalangiogramsareacquiredatlowerframeratesduringelectiveangiographyandpci‏ ‎‡A Impact of catheter sizes and intracoronary glyceryl trinitrate on the TIMI frame count when digital angiograms are acquired at lower frame rates during elective angiography and PCI.‏ ‎‡9 1‏
919 ‎‡a earlyinvasiveversusconservativetreatmentinpatientswithfailedfibrinolysisnolatesurvivalbenefitthefinalanalysisofthemiddlesbroughearlyrevascularisationtolimitinfarction‏ ‎‡A Early invasive versus conservative treatment in patients with failed fibrinolysis--no late survival benefit: the final analysis of the Middlesbrough Early Revascularisation to Limit Infarction‏ ‎‡9 1‏
919 ‎‡a cardiaccatheterisationradiationdosesandlifetimeriskofmalignancy‏ ‎‡A Cardiac catheterisation: radiation doses and lifetime risk of malignancy.‏ ‎‡9 1‏
919 ‎‡a successfulthrombusextractionwiththerescuethrombusmanagementsystemduringacutepercutaneouscoronaryinterventionimprovesflowbutdoesnotnecessarilyrestoreoptimalmyocardialtissueperfusion‏ ‎‡A Successful thrombus extraction with the Rescue thrombus management system during acute percutaneous coronary intervention improves flow but does not necessarily restore optimal myocardial tissue perfusion‏ ‎‡9 1‏
919 ‎‡a sstarssteroidsandstentsagainstrestenosistrialdifferentstentalloysandtheuseofperiproceduraloralcorticosteroidstopreventinsegmentrestenosisafterpercutaneouscoronaryintervention‏ ‎‡A The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention.‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2005‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 CAOONL|ncf11504313‏
996 ‎‡2 LC|n 85810601‏
996 ‎‡2 NII|DA01821727‏
996 ‎‡2 LC|no2013143598‏
996 ‎‡2 BNF|12113786‏
996 ‎‡2 N6I|vtls000040531‏
996 ‎‡2 NUKAT|n 98002366‏
996 ‎‡2 ISNI|0000000031730111‏
996 ‎‡2 BNCHL|10000000000000000183833‏
996 ‎‡2 ISNI|0000000032497286‏
996 ‎‡2 ISNI|000000049768089X‏
996 ‎‡2 RERO|A016393180‏
996 ‎‡2 ISNI|0000000449236145‏
996 ‎‡2 ISNI|0000000050887958‏
996 ‎‡2 CAOONL|ncf11962459‏
996 ‎‡2 ISNI|0000000025578272‏
996 ‎‡2 NLA|000035383949‏
996 ‎‡2 BNE|XX5054506‏
996 ‎‡2 LC|n 84081703‏
996 ‎‡2 ISNI|0000000038610526‏
996 ‎‡2 LC|no2012028942‏
996 ‎‡2 NLA|000035289957‏
996 ‎‡2 BIBSYS|99022291‏
996 ‎‡2 LC|no2016123158‏
996 ‎‡2 SUDOC|060707925‏
996 ‎‡2 NKC|xx0150829‏
996 ‎‡2 CAOONL|ncf10136457‏
996 ‎‡2 SIMACOB|11822179‏
996 ‎‡2 DNB|1161631771‏
996 ‎‡2 LC|no2021118648‏
996 ‎‡2 LC|n 95101037‏
996 ‎‡2 DBC|87097969500129‏
996 ‎‡2 ISNI|0000000080837222‏
996 ‎‡2 BAV|495_381948‏
996 ‎‡2 CAOONL|ncf10200685‏
996 ‎‡2 LIH|LNB:B_q_VP;=B_v_‏
996 ‎‡2 ISNI|0000000110028339‏
996 ‎‡2 NSK|000131569‏
996 ‎‡2 BNF|10355375‏
996 ‎‡2 BNF|10355374‏
996 ‎‡2 J9U|987007328406105171‏
996 ‎‡2 BNF|14184844‏
996 ‎‡2 ISNI|0000000046595557‏
996 ‎‡2 SUDOC|24128175X‏
996 ‎‡2 PLWABN|9810556124905606‏
996 ‎‡2 ISNI|0000000468129871‏
996 ‎‡2 NKC|xx0279509‏
996 ‎‡2 ISNI|0000000052015395‏
996 ‎‡2 BIBSYS|90179171‏
996 ‎‡2 DNB|139080317‏
996 ‎‡2 SUDOC|134009363‏
996 ‎‡2 J9U|987007444008805171‏
996 ‎‡2 ISNI|0000000031622305‏
996 ‎‡2 LC|nr 92003257‏
996 ‎‡2 LC|nr 92003254‏
996 ‎‡2 LC|no2022140903‏
996 ‎‡2 LC|nr 92003251‏
996 ‎‡2 ISNI|0000000024996333‏
996 ‎‡2 LC|no2003104863‏
996 ‎‡2 LC|nr 92003259‏
996 ‎‡2 DNB|143528785‏
996 ‎‡2 DNB|117415081‏
996 ‎‡2 DNB|1120346452‏
996 ‎‡2 BNCHL|10000000000000000181274‏
996 ‎‡2 NII|DA09328250‏
996 ‎‡2 NII|DA07655132‏
996 ‎‡2 BNF|14049719‏
996 ‎‡2 J9U|987007272628905171‏
996 ‎‡2 LC|no2024001208‏
996 ‎‡2 JPG|500036615‏
996 ‎‡2 ISNI|0000000067096407‏
996 ‎‡2 RERO|A003342312‏
996 ‎‡2 ISNI|000000004782143X‏
996 ‎‡2 RERO|A003342317‏
996 ‎‡2 ISNI|0000000027443347‏
996 ‎‡2 BNC|981058513790306706‏
996 ‎‡2 RERO|A003342314‏
996 ‎‡2 RERO|A016616477‏
996 ‎‡2 LC|n 81028852‏
996 ‎‡2 J9U|987007336030405171‏
996 ‎‡2 LC|no2016138729‏
996 ‎‡2 PLWABN|9810546053405606‏
996 ‎‡2 BNCHL|10000000000000000808066‏
996 ‎‡2 J9U|987007350952805171‏
996 ‎‡2 DE633|pe30095847‏
996 ‎‡2 ISNI|0000000077321591‏
996 ‎‡2 RERO|A022804581‏
996 ‎‡2 NTA|227901428‏
996 ‎‡2 J9U|987007436811205171‏
996 ‎‡2 LC|no2005081119‏
996 ‎‡2 ISNI|0000000074157669‏
996 ‎‡2 LC|n 2007072499‏
996 ‎‡2 DNB|140325506‏
996 ‎‡2 ISNI|0000000032046741‏
996 ‎‡2 SUDOC|129970441‏
996 ‎‡2 J9U|987007361554005171‏
996 ‎‡2 LC|n 97110821‏
996 ‎‡2 SUDOC|267112254‏
996 ‎‡2 LC|n 85312380‏
996 ‎‡2 LC|n 50017936‏
996 ‎‡2 DNB|1279187476‏
996 ‎‡2 DNB|1146514247‏
996 ‎‡2 SUDOC|02887997X‏
996 ‎‡2 DNB|135414334‏
996 ‎‡2 NTA|118532952‏
996 ‎‡2 LC|n 79054917‏
996 ‎‡2 SUDOC|192801538‏
996 ‎‡2 J9U|987007443499405171‏
996 ‎‡2 LC|n 2002014060‏
996 ‎‡2 LC|n 2007016324‏
996 ‎‡2 ISNI|0000000075374390‏
996 ‎‡2 LC|n 92104190‏
996 ‎‡2 SELIBR|300189‏
996 ‎‡2 LC|n 86004142‏
996 ‎‡2 DNB|1212550854‏
996 ‎‡2 CAOONL|ncf10032720‏
996 ‎‡2 J9U|987007335877405171‏
996 ‎‡2 LC|no2016089985‏
996 ‎‡2 ICCU|BVEV131839‏
996 ‎‡2 LC|no2011175658‏
996 ‎‡2 LC|n 83121953‏
996 ‎‡2 ISNI|0000000046127884‏
996 ‎‡2 LC|no2006067303‏
996 ‎‡2 LNB|LNC10-000039980‏
996 ‎‡2 LC|n 81123231‏
996 ‎‡2 BNE|XX1115405‏
996 ‎‡2 SUDOC|228315999‏
996 ‎‡2 NLA|000035701669‏
996 ‎‡2 NII|DA05836012‏
996 ‎‡2 LC|n 86825213‏
996 ‎‡2 N6I|vtls000030281‏
996 ‎‡2 N6I|vtls002498623‏
996 ‎‡2 ISNI|0000000077404485‏
996 ‎‡2 ICCU|NAPV200181‏
996 ‎‡2 LC|no2018071498‏
996 ‎‡2 LC|no2010156798‏
996 ‎‡2 ISNI|0000000497469277‏
996 ‎‡2 ISNI|0000000409962628‏
996 ‎‡2 NTA|072682329‏
996 ‎‡2 LC|n 84152147‏
996 ‎‡2 NII|DA14435114‏
996 ‎‡2 NKC|xx0030238‏
996 ‎‡2 SELIBR|58838‏
996 ‎‡2 RERO|A003342329‏
996 ‎‡2 DNB|138005451‏
996 ‎‡2 BIBSYS|97044790‏
996 ‎‡2 LC|no2009160878‏
996 ‎‡2 LC|n 88602775‏
996 ‎‡2 ISNI|0000000114590900‏
996 ‎‡2 LC|no2002023111‏
996 ‎‡2 BIBSYS|90064539‏
996 ‎‡2 ISNI|0000000436809426‏
996 ‎‡2 ISNI|0000000110863369‏
996 ‎‡2 RERO|A003342302‏
996 ‎‡2 BIBSYS|90237211‏
996 ‎‡2 DBC|87097990900250‏
996 ‎‡2 LIH|LNB:B_r_,Z;=B_v_‏
996 ‎‡2 SELIBR|300188‏
996 ‎‡2 BNC|981058617513806706‏
996 ‎‡2 CAOONL|ncf12052700‏
996 ‎‡2 LC|no2002034784‏
996 ‎‡2 SELIBR|300183‏
996 ‎‡2 BIBSYS|90645007‏
996 ‎‡2 SUDOC|243148453‏
996 ‎‡2 SELIBR|300187‏
996 ‎‡2 SELIBR|300186‏
996 ‎‡2 SELIBR|300185‏
996 ‎‡2 SELIBR|300184‏
996 ‎‡2 NKC|xx0115030‏
996 ‎‡2 J9U|987007388446505171‏
996 ‎‡2 ISNI|0000000082988278‏
996 ‎‡2 DNB|134396154‏
996 ‎‡2 ISNI|0000000038993037‏
996 ‎‡2 RERO|A009691609‏
996 ‎‡2 BIBSYS|90504530‏
996 ‎‡2 PLWABN|9810686654405606‏
996 ‎‡2 JPG|500339443‏
996 ‎‡2 BNF|10641428‏
996 ‎‡2 LC|no 99036965‏
996 ‎‡2 NTA|070813493‏
996 ‎‡2 LC|no 98007588‏
996 ‎‡2 LC|n 86063284‏
996 ‎‡2 LC|no2013076079‏
996 ‎‡2 SUDOC|026912740‏
996 ‎‡2 LC|n 96002545‏
996 ‎‡2 J9U|987007281920605171‏
996 ‎‡2 ISNI|000000003752890X‏
996 ‎‡2 BIBSYS|3081061‏
996 ‎‡2 LC|n 77010904‏
996 ‎‡2 NUKAT|n 97068183‏
996 ‎‡2 BNC|981058513790606706‏
996 ‎‡2 BNF|11906736‏
996 ‎‡2 CAOONL|ncf11171837‏
996 ‎‡2 BIBSYS|3011846‏
996 ‎‡2 SUDOC|146218310‏
996 ‎‡2 NII|DA1107835X‏
996 ‎‡2 LC|n 2005081993‏
996 ‎‡2 SIMACOB|147628387‏
996 ‎‡2 N6I|vtls002119618‏
996 ‎‡2 BIBSYS|5044395‏
996 ‎‡2 J9U|987007286698105171‏
996 ‎‡2 J9U|987007357528305171‏
996 ‎‡2 ICCU|RMSV628660‏
996 ‎‡2 NKC|skuk0002845‏
996 ‎‡2 DNB|1141911582‏
996 ‎‡2 LC|n 79010563‏
996 ‎‡2 LC|nr 94012433‏
996 ‎‡2 PTBNP|1169309‏
996 ‎‡2 BIBSYS|1082340‏
996 ‎‡2 LC|nr 95020805‏
996 ‎‡2 BNF|12062391‏
996 ‎‡2 BNF|17750731‏
996 ‎‡2 NSK|000107376‏
996 ‎‡2 LC|no 00084478‏
996 ‎‡2 LIH|LNB:I_y_B;=B_a_‏
996 ‎‡2 LC|no2014052946‏
996 ‎‡2 CAOONL|ncf11357202‏
996 ‎‡2 CAOONL|ncf11964402‏
996 ‎‡2 DNB|1088352154‏
996 ‎‡2 LC|nb2013010941‏
996 ‎‡2 J9U|987007444272505171‏
996 ‎‡2 NLA|000036010433‏
996 ‎‡2 ISNI|0000000033300588‏
996 ‎‡2 J9U|987007394736105171‏
996 ‎‡2 LC|no 98086559‏
996 ‎‡2 LC|n 88110798‏
996 ‎‡2 ISNI|0000000117603711‏
996 ‎‡2 LC|n 97880656‏
996 ‎‡2 BNF|10355376‏
996 ‎‡2 LC|nb2014017233‏
996 ‎‡2 LC|no2009071275‏
996 ‎‡2 BIBSYS|1602157054567‏
996 ‎‡2 ISNI|0000000381934288‏
996 ‎‡2 B2Q|0001522065‏
996 ‎‡2 NII|DA16839726‏
996 ‎‡2 PLWABN|9810546053905606‏
996 ‎‡2 CAOONL|ncf10105688‏
996 ‎‡2 SELIBR|300200‏
996 ‎‡2 BNF|15059432‏
996 ‎‡2 ISNI|0000000114883914‏
996 ‎‡2 J9U|987007279061105171‏
996 ‎‡2 SUDOC|267155832‏
996 ‎‡2 BIBSYS|98055623‏
996 ‎‡2 CAOONL|ncf10220095‏
996 ‎‡2 ISNI|000000042845467X‏
996 ‎‡2 NKC|ola2008474539‏
996 ‎‡2 BNC|981058615730306706‏
996 ‎‡2 DNB|1122060750‏
996 ‎‡2 SUDOC|029530830‏
996 ‎‡2 ISNI|0000000114544453‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏